In our current investigation, plumbagin could down-regulate the expressions of inflammatory factors and MMPs by up-regulating IκB and inhibiting the activation of NF-κB so as to reduce joint damage caused by RA. Here, NFKB1 is linked to rheumatoid arthritis.